In Silico identification of inhalable small-molecule IL-33/ST2 antagonists for severe type-2-high asthma endotypes. [PDF]
Sun G, Liu Q, Yu M, Han K, Huang L.
europepmc +1 more source
Beyond inhaled medications: precision medicine and biologic therapies targeting the IL-33/TSLP/type 2 axis in COPD. [PDF]
Song GQ, Chen B, He TL, Hu GQ.
europepmc +1 more source
HSP70 is a chaperone for IL-33 activity in chronic airway disease. [PDF]
Osorio OA +11 more
europepmc +1 more source
Distinct Roles for Thymic Stromal Lymphopoietin (TSLP) and IL-33 in Experimental Eosinophilic Esophagitis. [PDF]
Dsilva A +16 more
europepmc +1 more source
Does IL-31 level have more significance in chronic urticaria, when compared with IL-33 level? [PDF]
Özden G +5 more
europepmc +1 more source
Senescence‑associated IL‑33 secretion undermines sorafenib efficacy in hepatocellular carcinoma via immune evasion. [PDF]
Lin YX +7 more
europepmc +1 more source
CCL5 deficiency aggravates acute DSS-induced colitis by restricting IL-33-induced formation of Tregs in intestinal tract. [PDF]
Luo Y +8 more
europepmc +1 more source

